Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...
EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...
Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...
Dr. Anne Marie Morse, an internationally recognized leader in neurology and sleep medicine, as Chairwoman of its newly formed Clinical Advisory Board. In this role, Dr. Morse will collaborate with ...
One way Takeda lives out its values is by striving to ensure that patients are aware of and can access the company’s clinical ...
A structured data ownership model—rooted in ICH GCP principles, supported by MHRA and FDA interpretations, and documented in validated system specifications—will enable sponsors to maintain compliance ...
Investing.com -- Theriva Biologics Inc (NYSE American:TOVX) stock surged 25.4% in Monday premarket trading after the company announced receiving positive scientific advice from the European Medicines ...
The concept of saline nasal irrigation, or bathing the nasal passages with a saltwater solution, is thought to have been ...
Intelligencer on MSNOpinion
Why Nicholas Maduro Is Facing Trial in Lower Manhattan
The Southern District of New York offers some distinct advantages in a case as wild and high-profile as this one.
True ROI for R&D won't come from the tool that generates 10,000 new ideas. It will come from the tool that confidently tells ...
Theriva Biologics (TOVX) announced the receipt of Scientific Advice from the Committee for Medicinal Products for Human Use ...
EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC, including sample size ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback